Zai aiming to gain dual listing via Hong Kong offering

Zai’s planned offering that could raise close to $900 million would make it a dual-listed company in Hong Kong and on NASDAQ.

Zai Lab Ltd. (NASDAQ:ZLAB) has launched a Hong Kong offering and simultaneous international offering due to price on Sept. 22. The cross-border company in-licenses local rights to therapeutics from Western companies and seeks to gain their approval in China and other Asian territories...